OGN vs XLV
Organon & Co (OGN) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
XLV does not have a complete income-statement cache yet.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. XLV currently screens at market cap $0.
Not investment advice. Open the OGN and XLV stock pages for the full models.
Not investment advice.